This inventor holds 2 USPTO granted patents. Top assignees: Centre National De La Recherche Scientifique, Philippe Yves-Remy Simon, Universitë De Bordeaux. Active years: 2019-2021.
Company Filing History:
1 out of 5,383 
1 out of 1 
1 out of 226 
Years Active: 2019-2021
Title: Gérard Audran: Innovator in Cancer Treatment
Introduction
Gérard Audran is a notable inventor based in Marseilles, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of cancer and neurodegenerative disorders. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Audran's latest patents include "Proteasome inhibiting β-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders." This invention focuses on compounds that inhibit the proteasome, offering new avenues for treating these serious health conditions. Additionally, he has developed a patent for "Alkoxyamines for the treatment of cancers," which involves specific chemical compounds aimed at combating cancer.
Career Highlights
Throughout his career, Audran has worked with various companies, including Philippe Yves-Rémy Simon and Vita Api. His innovative approach and dedication to research have positioned him as a key figure in pharmaceutical development.
Collaborations
Some of his notable coworkers include Philippe Yves-Rémy Simon and Henri Oreal. Their collaborative efforts have contributed to the advancement of research in the pharmaceutical industry.
Conclusion
Gérard Audran's work exemplifies the spirit of innovation in the medical field. His patents and collaborations reflect a commitment to improving treatment options for cancer and neurodegenerative disorders.